Know Cancer

or
forgot password

NOPHO-DBH AML 2012 Protocol. Research Study for Treatment of Children and Adolescents With Acute Myeloid Leukaemia 0-18 Years


Phase 3
N/A
18 Years
Open (Enrolling)
Both
Pediatric Acute Myeloblastic Leukemia

Thank you

Trial Information

NOPHO-DBH AML 2012 Protocol. Research Study for Treatment of Children and Adolescents With Acute Myeloid Leukaemia 0-18 Years


Inclusion Criteria:



1. AML as defined by the WHO diagnostic criteria

2. Age < 19 years at time of diagnosis

3. Written informed consent

Exclusion Criteria:

1. Previous chemotherapy or radiotherapy. This includes patient with secondary AML after
previous cancer therapy

2. AML secondary to previous bone marrow failure syndrome.

3. Down syndrome (DS)

4. Acute promyelocytic leukaemia (APL)

5. Myelodysplastic syndrome (MDS)

6. Juvenile Myelomonocytic Leukaemia (JMML)

7. Known intolerance to any of the chemotherapeutic drugs in the protocol.

8. Fanconi anaemia

9. Major organ failure precluding administration of planned chemotherapy.

10. Positive pregnancy test

11. Lactating female or female of childbearing potential not using adequate contraception

Type of Study:

Interventional

Study Design:

Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Factorial Assignment, Masking: Open Label, Primary Purpose: Treatment

Outcome Measure:

Minimal residual disease

Outcome Description:

MRD will be measured by flow cytometry. In the randomisation for course 1 the endpoint is at day 22. In the randomisation for course 2 the endpoint is immediately before start of consolidation

Outcome Time Frame:

On day 22 after the first induction and after second induction

Safety Issue:

No

Principal Investigator

Jonas Abrahamsson, MD, PhD

Investigator Role:

Study Chair

Investigator Affiliation:

Children's Cancer Centre, Queen Silvias Childrens and Adolescents Hospital 416 85 Gothenburg, Sweden

Authority:

Sweden: Medical Products Agency

Study ID:

NOPHO-DBH-AML2012

NCT ID:

NCT01828489

Start Date:

March 2013

Completion Date:

March 2023

Related Keywords:

  • Pediatric Acute Myeloblastic Leukemia
  • Leukemia
  • Leukemia, Myeloid, Acute
  • Leukemia, Myeloid

Name

Location